Single-Use Technology Usage by Industry
Monoclonal Antibodies (mAbs)
Research & Development (R&D)
Vaccine Production
Gene Therapy Production
Other
Monoclonal
Antibodies (mAbs)
30%
Research & Development (R&D)
20%
Vaccine Production
15%
Gene Therapy
Production
12%
Other
23%